33.6 C
Casper
Thursday, August 7, 2025

TAG

Emerging Technology

naturalX Ventures Closes €100M Fund for Consumer Health Startups

naturalX Ventures announces the close of its €100M VC fund, targeting Series A investments in consumer health startups across Europe and select North American markets.

Luminance Raises $75M to Power Global Legaltech Growth

London-based Luminance secures $75M Series C led by Point72 to boost its AI-driven legal platform and expand in the US, APAC, and Europe.

Niantic Explores Sale of Game Development Unit to Scopely

Niantic may sell its game development unit to Scopely for $3.5M. The move follows layoffs and canceled projects.

Cashfree Raises $53M to Expand Globally, Valued at $700M

Payments startup Cashfree secures $53M led by Krafton. With a $700M valuation, it targets global markets, offering seamless payment solutions and fraud prevention tools.

EnterOne Acquires TLG Learning to Expand IT Training

EnterOne acquires TLG Learning, enhancing vendor-certified IT training, expanding its U.S. presence, and empowering professionals in the digital economy.

SoftBank and Quantinuum Partner to Advance Quantum AI

SoftBank and Quantinuum collaborate to integrate AI & quantum computing, unlocking innovations, solving complex challenges, and shaping next-gen technologies.

Practus, Pathsetter AI Launch DisruptIQ for Smarter Insights

Practus partners with Pathsetter AI to launch DisruptIQ, an AI-powered analytics solution driving data-driven decisions, growth, and profitability.

Microsoft in Talks to Buy TikTok as Trump Pushes Bidding War

President Trump confirms Microsoft’s talks to acquire TikTok, urging a bidding war. AI startup Perplexity also makes a bid. Decision expected in 30 days.

Infosys and Siemens Expand AI-Powered Learning Collaboration

Infosys and Siemens enhance digital learning with GenAI, offering 250,000+ employees personalized upskilling via AI-powered tools and smart learning features.

BenevolentAI Restructures, Focuses on Core AI Tech

BenevolentAI refocuses on its AI-driven drug discovery roots, streamlining operations, exploring delisting, and extending its cash runway to 2027.

Latest news